July/August 2017

 

In this Issue

Let's Talk Pharmacology

Therapeutic options for the management of retinal disease continue to emerge and evolve.

  • Issue

  • Insert

  • Supplement

 
View the E-Dition

UP FRONT

Medical Editors' Page

Each Issue a Recipe

By Allen C. Ho, MD, and Robert L. Avery, MD

Medical Update

A summary of general medical news that affects your patients, your practice, and you.

By Section Editor David S. Boyer, MD
Fellows' Focus

Growing Pains in Retina

Tips for attending physicians entering their first ophthalmology practices from those who recently made the transition.

By Christopher M. Aderman, MD; Ferhina Ali, MD; and Katherine Talcott, MD

RETINA SURGERY

Retina Pearls

Further Refining the Ideal Macular Hole Repair

A trifecta of articles adds new details.

By Brian C. Joondeph, MD, MPS
Global Perspectives

When and How to Treat Myopic Traction Maculopathy

Surgical technique should be chosen based on detailed evaluation.

By Keiko Kataoka, MD, PhD, and Hiroko Terasaki, MD, PhD

MEDICAL RETINA

Papillophlebitis: a Closer Look

Basic awareness of a rare condition may help avoid unnecessary diagnostic measures and expedite proper treatment.

By Andrea Grosso, MD; Jorge I. Calzada, MD; John Randolph, MD; and Eric Sigler, MD

OCULAR ONCOLOGY

Updated Classification for Primary Iris Melanoma

Key characteristics of the American Joint Committee on Cancer’s revised classification system.

By Vladislav P. Bekerman, BS; Maura Di Nicola, MD; Jerry A. Shields, MD; and Carol L. Shields, MD

IMAGING

Heads-up 3-D Visualization in Complex Vitreoretinal Surgery

The latest dimension in surgical viewing works well in many scenarios, including complex cases.

By Maxwell S. Stem, MD; Aristomenis Thanos, MD; Dean Eliott, MD; Kimberly A. Drenser, MD, PhD; Tarek S. Hassan, MD; Alan J. Ruby, MD; George A. Williams, MD; and Yoshihiro Yonekawa, MD

COVER FOCUS: LET’S TALK PHARMACOLOGY

Introduction

Intravitreal Monotherapy for CRVO, or Intravitreal Therapy Plus Laser?

Which approach to treatment is best for patients with CME secondary to central retinal vein occlusion?

By Manrique Cordoba, MD, and Lihteh Wu, MD

Intravitreal Anti-VEGF Injection Treatment Algorithms for DME

Benefits and limitations of common approaches to managing patients with diabetic macular edema.

By Christopher M. Aderman, MD, and Sunir J. Garg, MD

Anti-Integrin Therapy in Treatment of DME

Agent shows novel mechanism of action, binding in the retina to stop angiogenesis.

By Peter K. Kaiser, MD

Dry AMD Pipeline: Looking to Intravitreal Therapy

Two oral drugs for nonneovascular AMD have had disappointing results in clinical trials.

By Pravin U. Dugel, MD

IN THE BACK

5Q With Amy C. Schefler, MD, FACS

Amy C. Schefler, MD, FACS, is a surgeon at Retina Consultants of Houston, Blanton Eye Institute, Houston Methodist Hospital, and a surgeon at Children’s Memorial Hermann Hospital, University of Texas Health Sciences.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.